ADVM - Adverum Biotechnologies - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart

Adverum Biotechnologies's activity chart (see below) currently has 66 price targets and 70 ratings on display.

Stock Analyst Price Targets - Review

Analysts' price targets on this stock were met 43.13% of the time, taking 324.72 days on average.

Most recent stock forecast was given by from HC WAINWRIGHT on 17-Nov-2025.

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 30-Apr-2024

$5

1 years 4 days ago
(17-Nov-2025)

0/5 (0%)

$0.73 (17.10%)

Buy Since 01-Nov-2023

$5.5

$12

1 years 23 days ago
(29-Oct-2025)

1/7 (14.29%)

$1.27 (30.02%)

292

Hold Since 16-Apr-2025

$4

$5

1 years 24 days ago
(28-Oct-2025)

1/2 (50%)

$-0.26 (-6.10%)

168

Buy Since 18-Jul-2024

1 years 3 months 8 days ago
(13-Aug-2025)

2/3 (66.67%)

$30.52 (321.94%)

1046

Hold Since 19-Mar-2024

$4

$5

1 years 6 months 6 days ago
(15-May-2025)

4/6 (66.67%)

$1.95 (95.12%)

205

Show more analysts

Please expand the browser size to see the chart

What is ADVM (Adverum Biotechnologies) average time for price targets to be met?

On average it took 325 days for the stock forecasts to be reached, with an average price target met ratio of 43.13%.

Which analyst most recently updated their price target on ADVM (Adverum Biotechnologies)?

Which analyst has the most public recommendations on ADVM (Adverum Biotechnologies)?

has 0 price targets and 0 ratings on ADVM

Which analyst is the currently most bullish on ADVM (Adverum Biotechnologies)?

Biren Amin with the highest potential upside of $505.64

Which analyst is the currently most reserved on ADVM (Adverum Biotechnologies)?

Luca Issi with the lowest potential downside of -$0.36
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?